Drugs Channel
Topics & Medications
Related Channels

Ibritumomab Side Effects

Common Side Effects

Ibritumomab has been studied extensively in clinical trials. In these studies, the side effects that occurred in a group of people who received the drug were carefully documented. As a result, it was possible to see what side effects occurred and how often they appeared.
In clinical studies, the most common ibritumomab side effects included:
  • Low platelet counts -- in up to 62 percent of people
  • Low white blood cell counts -- up to 45 percent
  • Fatigue -- up to 33 percent
  • Low red blood cell counts (anemia) -- up to 22 percent
  • Symptoms of the common cold -- up to 19 percent
  • Nausea -- up to 18 percent
  • Abdominal (stomach) pain -- up to 17 percent
  • Weakness -- up to 15 percent
  • Coughing -- up to 11 percent
  • Diarrhea -- up to 11 percent
  • Fever -- up to 10 percent.
Other common reactions, occurring in 5 percent to 9 percent of people, included:

Final Thoughts

You may experience some or none of the ibritumomab side effects listed in this article. Unfortunately, there is no way for your healthcare provider to know beforehand if you will have problems with a medicine that you have never tried.
Therefore, make sure to let your healthcare provider know if you develop any side effects while receiving ibritumomab or if something "just does not seem right." While it may not be related to the medication, your healthcare provider will be able to diagnose and treat the problem.
The Zen of Cancer Caregiving - Recharge Your Batteries!

Ibritumomab Drug Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.